Clinical Trial Update: A Study of ARRY-502 in Patients With Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 study of ARRY-502 in persistent asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ARRY-502

Snippet

Sponsor: Pfizer | Conditions: Asthma | Phase 2 | Status: COMPLETED